Stock Alert: Cerecor Shares Up 21% In Early Trading

Shares of Cerecor Inc. (CERC) are rising over 21% in pre-market today, after the company announced exploration of the role of an inflammatory cytokine, LIGHT, in COVID-19 patients with acute lung injury leading to Acute Respiratory Distress Syndrome.

The company noted that it would use its proprietary free LIGHT assay as well as a multiplex assay to determine whether there are differences in LIGHT levels and other inflammatory markers including IL-18 and IFN-g in patients with mild to moderate vs severe disease with Acute Lung Injury / Acute Respiratory Distress Syndrome or ARDS.

The stock has been trading between $1.52 and $6.47 in the past one year, and closed Wednesday's trade at $2.64, down 33 cents or 11.11%. CERC is currently trading at $3.20, up 56 cents or 21.20% in the pre-market trading session.

For comments and feedback contact: editorial@rttnews.com

Business News

Invest in the Best Pharma Stocks by Subscribing to RTT Biotech Investor.
Follow RTT